首页|脉通君安汤治疗气虚血瘀型冠心病心绞痛的临床疗效及转录组学研究

脉通君安汤治疗气虚血瘀型冠心病心绞痛的临床疗效及转录组学研究

扫码查看
目的 观察脉通君安汤治疗气虚血瘀型冠心病心绞痛的临床疗效,并通过转录组学方法初步阐明其可能的作用机制.方法 将符合纳入标准的 140 例气虚血瘀型冠心病心绞痛患者依据随机数字法分为治疗组、对照组各 70 例,治疗期间对照组脱落 3 例.对照组予冠心病二级预防西医基础治疗,治疗组在对照组治疗基础上加服脉通君安汤,2 组疗程均为 8 周.治疗前后评估 2 组患者中医证候积分、加拿大心血管学会(Canadian cardiovascular society,CCS)心绞痛分级、西雅图量表(Seattle angina questionnaire,SAQ)评分、焦虑自评量表(Self-rating anxiety scale,SAS)评分、抑郁自评量表(Self-rating depression scale,SDS)评分及不良反应,并基于性别、年龄、病程相匹配原则选取 9 例患者治疗前后外周血进行转录组学测序.结果 治疗后,2 组患者中医证候积分均明显下降(P<0.01),治疗组在改善胸痛、胸闷、气短、神倦乏力及总分方面优于对照组(P<0.05,P<0.01);治疗组CCS心绞痛分级总改善率优于对照组(P<0.05);2 组治疗前后SAQ、SAS及SDS评分均显著改善(P<0.01),治疗组SAQ评分改善优于对照组(P<0.05,P<0.01).转录组学结果显示,治疗前后具有显著差异表达的mRNA有 862 个,包括509 个上调,353 个下调;GO分析结果显示差异表达的mRNA生物学过程有 666 条,主要包括病毒基因表达、翻译启动、RNA分解代谢过程等,细胞组分 112 条,主要包括黏着斑、核糖体亚基、核斑点等;分子功能有 94 条,主要包括双链RNA结合、钙黏蛋白结合、转录共调节因子活性等;KEGG分析结果显示差异mRNA富集信号通路包括 20 条,主要包括甘油磷脂代谢通路、单磷酸腺苷激活的蛋白激酶(AMP-activated protein kinase,AMPK)信号通路、核糖体通路等.结论 脉通君安汤能够改善气虚血瘀型冠心病心绞痛患者临床症状,其作用机制为多靶点多通路,可能与甘油磷脂代谢通路、AMPK信号通路、核糖体通路的调节相关.
Clinical Efficacy and Transcriptomic Study on the Treatment of Coronary Heart Disease Angina of Qi Deficiency and Blood Sta-sis Type with Maitong Jun'an Decoction
OBJECTIVE To observe the clinical efficacy of Maitong Jun'an Decoction in treating coronary heart disease(CHD)angina of qi deficiency and blood stasis type,and preliminarily elucidate its possible mechanism of action through transcriptomics meth-ods.METHODS A total of 140 patients with CHD angina of qi deficiency and blood stasis type were included and randomly divided into a treatment group and a control group,with 70 cases in each group.During the treatment period,3 patients in the control group dropped out.The control group received basic Western medicine treatment for secondary prevention of CHD,while the treatment group received Maitong Jun'an Decoction in addition to the treatment in the control group.The treatment period for both groups was 8 weeks.Before and after treatment,the patients in both groups were evaluated for the TCM syndrome score,Canadian Cardiovascular Society(CCS)angina grading,Seattle angina questionnaire(SAQ)score,self-rating anxiety scale(SAS),self-rating depression scale(SDS)score,and adverse reactions.The peripheral blood of 9 patients before and after treatment was selected for transcriptomic sequencing based on the principle of gender,age,and disease duration matching.RESULTS After treatment,the TCM syndrome scores and total scores of the 2 groups were significantly reduced(P<0.01).The treatment group was better than the control group in improving chest pain,chest tightness,shortness of breath,fatigue and total score(P<0.05,P<0.01);the overall improvement rate of CCS angina grading in the treatment group was better than that in the control group(P<0.05);the SAQ,SAS and SDS scores of the 2 groups were significantly reduced before and after treatment(P<0.01),and the SAQ score of the treatment group was improved better than that of the control group(P<0.05,P<0.01).The transcriptomics results showed that there were 862 significantly different mR-NAs before and after treatment,including 509 up-regulated and 353 down-regulated.GO analysis showed that there were 666 biologi-cal processes in the differentially expressed mRNAs,mainly including viral gene expression,translation initiation,RNA catabolism,etc.There were 112 cell components,mainly including focal adhesion,ribosome subunit,nuclear spot,etc.There were 94 molecular functions,mainly including double-stranded RNA binding,cadherin binding,transcription co-regulatory factor activity,etc.KEGG analysis showed that the differentially expressed mRNAs enriched in 20 signaling pathways,mainly including glycerophospholipid me-tabolism pathway,AMPK signaling pathway,ribosome pathway,etc.CONCLUSION Maitong Jun'an Decoction can improve clini-cal symptoms in patients with CHD angina of qi deficiency and blood stasis type.Its mechanism of action is multi-target and multi pathway,mainly related to the regulation of glycerophospholipid metabolism pathway,AMPK signaling pathway,ribosome pathway.

Maitong Jun'an Decoctioncoronary heart diseaseanginaqi deficiency and blood stasis syndrometranscriptome se-quencingrandomized controlled trialinvigorating qi and promoting blood circulation

王子杨、刘美志、胡晓贞、周苗、翁嘉灏、赖志昆、孙永宁

展开 >

上海中医药大学附属市中医医院,上海 200071

脉通君安汤 冠心病 心绞痛 气虚血瘀证 转录组测序 随机对照试验 补气活血法

国家重点研发计划主动健康和老龄化科技应对重点专项上海市公共卫生体系建设三年行动计划重点学科建设项目(2020-2022)上海市科委科研项目上海市中医医院未来计划

2018YFC2002504GWV-10.1-XK2021Y11920700WLJH2021ZY-MZY018

2024

南京中医药大学学报
南京中医药大学

南京中医药大学学报

CSTPCD北大核心
影响因子:1.658
ISSN:1672-0482
年,卷(期):2024.40(4)
  • 36